2m 2m 2m 2m 2m 2m 2m
Akebia Therapeut (AKBA)
NASDAQ
$0.58+$0.003 (+0.58%)
Price as of Nov 12, 2026 8:17 AM EST- $159.3MMarket Cap
- -68.99%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
Akebia Therapeut (AKBA)
$0.58+$0.003 (+0.58%)
AKBA | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $0.57 | ||
Change | +$0.03 (+5.89%) | ||
Open | $0.53 | ||
High | $0.58 | ||
Low | $0.52 | ||
Previous Close | $0.54 | ||
Volume | 3,682,408 | ||
30-Day Average Volume | 9,401,326 | ||
1-Week Change | -17.42% | ||
1-Month Change | -28.39% | ||
1-Year Change | -68.99% | ||
3-Year Change | -35.76% | ||
5-Year Change | -80.55% | ||
Fundamentals | |||
Shares Outstanding | 277.7M | ||
Total Assets | $342.1M | ||
Market Cap | $159.3M | ||
Enterprise Value | $50.3M | ||
Period: QTR TTM FY | |||
Revenue | $0.00 | ||
Net Income | -$14.4M | ||
Free Cash Flow | $1.6M | ||
EBIT | -$11.0M | ||
EBITDA | -$10.9M | ||
Net Working Capital | $58.4M | ||
EPS | -$0.05 | ||
Enterprise Value/EBITDA | -5 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 8 | ||
P/E | -11 | ||
PEG | 0 | ||
Price/Free Cash Flow | 98 | ||
Price/Operating Cash Flow | 68 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue